Perry Sternberg

Shire expands its portfolio of intravenous and subcutaneous immunoglobulin (IG) products with U.S. FDA approval of CUVITRU

Approval follows positive data from clinical studies on efficacy and tolerability, as well as infusion time and number of injection…

8 years ago

Shire plc: U.S. FDA approved the BAXJECT III reconstitution system for ADYNOVATE

New system reduces number of steps in the treatment process for hemophilia A patients on ADYNOVATE [Antihemophilic Factor, (Recombinant), PEGylated]…

8 years ago